Hybrid Coronary Revascularization Trial
Public ClinicalTrials.gov record NCT03089398. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to learn which treatment option is better for patients who have multi-vessel coronary artery disease (blockages in more than one vessel supplying blood to the heart muscle). The treatment options this study will compare are: (1) Hybrid Coronary Revascularization \[HCR\] (a combination of surgery and catheter procedures to open up clogged heart arteries) and (2) Percutaneous Coronary Intervention \[PCI\] (catheter procedures alone to open up clogged heart arteries). There are no new or "experimental" procedures being tested in this study: both HCR and PCI are well-established procedures and are regularly performed in patients who have coronary artery disease. But, the FDA has not approved the drug-eluting stents used in PCI for all types of coronary artery disease. We have received an Investigational Device Exemption from the FDA to use the drug-eluting stents in this trial in the same way that they are used in clinical practice. The study being proposed here will use rigorous scientific methods and should result in a very high level of certainty about which procedure is best for patients with coronary artery disease.
Study identification
- NCT ID
- NCT03089398
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Hybrid Coronary Revascularization (isolated LIMA-LAD) Procedure
- Hybrid Coronary Revascularization (PCI) Device
- Percutaneous Coronary Intervention Device
Procedure · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 9, 2017 (Actual)
- Primary completion
- Mar 31, 2021 (Actual)
- Completion
- Sep 30, 2021 (Actual)
- Last update posted
- May 23, 2025
2017 – 2021
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Long Beach Memorial Medical Center | Long Beach | California | 90806 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of California Los Angeles | Los Angeles | California | 90095 | — |
| Stanford University | Stanford | California | 94305 | — |
| Yale University | New Haven | Connecticut | 06510 | — |
| HealthPark Lee Memorial Health Systems | Fort Myers | Florida | 33908 | — |
| Orlando Health Heart Institute | Orlando | Florida | 32806 | — |
| Emory University Hospital Midtown | Atlanta | Georgia | 30308 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Maryland | College Park | Maryland | 20742 | — |
| Universty of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Our Lady of Lourdes Medical Center | Camden | New Jersey | 08103 | — |
| Buffalo General Medical Center/Gates Vascular Institute | Buffalo | New York | 14203 | — |
| Mount Sinai Beth Israel | New York | New York | 10003 | — |
| Columbia University Medical Center/New York Presbyterian Hospital | New York | New York | 10032 | — |
| Lenox Hill Hospital | New York | New York | 10075 | — |
| St. Joseph's Hospital Health Center | Syracuse | New York | 13203 | — |
| Montefiore - Einstein | The Bronx | New York | 10461 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| WakeMed Health and Hospitals | Raleigh | North Carolina | 27610 | — |
| Wake Forest Baptist Medical Center | Winston-Salem | North Carolina | 27157 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| University of Toledo Medical Center | Toledo | Ohio | 43614 | — |
| Pinnacle Health Cardiovascular System | Harrisburg | Pennsylvania | 17104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Einstein Healthcare Network | Philadelphia | Pennsylvania | 19141 | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
| The Reading Health System | West Reading | Pennsylvania | 19611 | — |
| Lankenau Medical Center | Wynnewood | Pennsylvania | 19096 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Erlanger Health System | Chattanooga | Tennessee | 37403 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Baylor Research Institute at The Heart Hospital Baylor Plano | Plano | Texas | 75093 | — |
| University of Virginia | Charlottesville | Virginia | 22903 | — |
| Inova Fairfax Medical Campus | Falls Church | Virginia | 22042 | — |
| Gundersen Health System | La Crosse | Wisconsin | 54601 | — |
| University of Wisconsin | Madison | Wisconsin | 53706 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03089398, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 23, 2025 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03089398 live on ClinicalTrials.gov.